Real-World Evidence Conference

This session will explore emerging trends for the future of Real World Evidence (RWE) and the complementary value of advanced analytics. The speakers will focus on the growing role of RWE for decision making, using the approach of emulating Randomized Controlled Trials (RCTs). We will address how new sources of data can be combined with more traditional research databases to provide much richer and more informative data for conducting studies, such as Patient Generated Health Data (PGHD), omics, and imaging. The session will also address challenges in combining advanced analytics with more established designs and methods. Advances in using AI-based image analysis of tumors that will facilitate the inclusion of AI-analyzed tumor images into classical RWE databases with be reviewed. Finally, the topic of how the UK researchers have been able to include genomic data into EHR databases for the purposes of RWE studies will be discussed.